"Researchers Find Chemotherapy after Bladder Cancer Surgery Improved Survival"
Patients that received chemotherapy after bladder cancer surgery demonstrated an approximately 30% lower risk of death than those that underwent surgery alone, according to an analysis to be presented by researchers at the Icahn School of Medicine at Mount Sinai at the 2015 Genitourinary Cancers Symposium. Lead researcher Matthew Galsky, MD and colleagues used a large database of patients diagnosed with cancer in the United States. Specifically, the study found that patients receiving adjuvant chemotherapy after surgical treatment had improved overall survival when compared to patients that received surgical treatment alone with only post-surgical observation. "Until now, data supporting adjuvant chemotherapy has been mixed," said lead Dr. Galsky, Associate Professor of Medicine, Hematology and Medical Oncology, and Assistant Professor, Urology at the Icahn School of Medicine at Mount Sinai. Learn more.
AI-Driven Study Redefines Right Heart Health Assessment With Novel Predictive Model
Jan 04, 2024 View All Press ReleasesDemystifying a Key Receptor in Substance Use and Neuropsychiatric Disorders
Jan 02, 2024 View All Press ReleasesNew Insights Revealed On Tissue-Dependent Roles of JAK Signaling in Inflammation
Dec 21, 2023 View All Press ReleasesA Type of Allergy Medicine Might Help Treat Lung Cancer, Research Suggests
Dec 06, 2023 View All Press Releases